On December 12, 2024, the annual Postdoctoral Talent Development Conference, hosted by the Beijing Municipal Bureau of Human Resources and Social Security, was held at the Beijing International Wealth Center. At the conference, our company was awarded the plaque for the Postdoctoral Research Workstation jointly by the Ministry of Human Resources and Social Security and the National Postdoctoral Administration Committee. This recognition marks another step forward for our company following its 2023 designation as the Beijing Postdoctoral Innovation and Practice Base, underscoring our firm commitment to advancing technological innovation and cultivating high-end professional talent, as well as our vigorous and upward trajectory of development.
NORTHLAND has always adhered to innovation-driven development and is committed to the research and development of gene therapy drugs, recombinant protein drugs, and ophthalmic products. The recent approval to establish a postdoctoral research workstation is a strong recognition and trust from the talent management authorities in our company’s technological innovation capabilities and talent cultivation capacity, providing a new platform for building our talent team and attracting and nurturing high-level young talents.
The company will leverage its postdoctoral research workstation as a platform, collaborating with postdoctoral stations at universities and research institutes to effectively recruit postdoctoral researchers. We will fully harness the institutional advantages of the postdoctoral program, establish and refine comprehensive regulations and detailed operational guidelines for postdoctoral management, and ensure the effective recruitment, training, and utilization of postdoctoral researchers. We will also organize and carry out cutting-edge scientific research, accelerate the development of new drugs, promote the commercialization of scientific and technological achievements, further enhance our company’s independent innovation capabilities and technological competitiveness, and make positive contributions to the cultivation of high-level talent in China’s pharmaceutical sector.